col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


19 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Cell Death and Differentiation
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―21 Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality Marie-Christine Albert, Iratxe Uranga-Murillo, Maykel Arias, Diego De Miguel, Natacha Peña, Antonella Montinaro, et al. (+22)
2 [GO] 2023―Aug―15 Ferroptosis and pyroptosis signatures in critical COVID-19 patients Cédric Peleman, Samya Van Coillie, Symen Ligthart, Sze Men Choi, Jan De Waele, Pieter Depuydt, et al. (+13)
3 [GO] 2022―May―17 Immune response in COVID-19: what is next? Qing Li, Ying Wang, Qiang Sun, Jasmin Knopf, Martin Herrmann, Liangyu Lin, et al. (+21)
4 [GO] 2022―Jan―22 T cell apoptosis characterizes severe Covid-19 disease Sonia André, Morgane Picard, Renaud Cezar, Florence Roux-Dalvai, Aurélie Alleaume-Butaux, Calaiselvy Soundaramourty, et al. (+27)
5 [GO] 2022―Jan―17 Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence Liangyu Lin, Ying Wang, Qing Li, Mingyuan Hu, Yufang Shi
6 [GO] 2022―Jan―12 SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK Yang Yang, Yongjian Wu, Xiaojun Meng, Zhiying Wang, Muhammad Younis, Ye Liu, et al. (+2)
7 [GO] 2022―Jan―08 SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1 Xiao Sun, Yingzhi Liu, Ziheng Huang, Wenye Xu, Wei Hu, Lina Yi, et al. (+22)
8 [GO] 2021―Oct―18 Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19 Toshifumi Matsuyama, Steven K. Yoshinaga, Kimitaka Shibue, Tak W. Mak
9 [GO] 2021―Aug―17 Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection Marcello Allegretti, Maria Candida Cesta, Mara Zippoli, Andrea Beccari, Carmine Talarico, Flavio Mantelli, et al. (+3)
10 [GO] 2021―Aug―13 SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse Hongyan Huang, Yichao Zhu, Zubiao Niu, Lulin Zhou, Qiang Sun
11 [GO] 2021―Jul―06 Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis Anne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud, François-Xavier Danlos, Safae Terrisse, Carolina Alves Costa Silva, et al. (+63)
12 [GO] 2021―May―24 Patients with COVID-19: in the dark-NETs of neutrophils Maximilian Ackermann, Hans-Joachim Anders, Rostyslav Bilyy, Gary L. Bowlin, Christoph Daniel, Rebecca De Lorenzo, et al. (+41)
13 [GO] 2021―May―12 Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes Liangyu Lin, Qing Li, Ying Wang, Yufang Shi
14 [GO] 2021―Apr―20 SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination Zhengrong Zhang, You Zheng, Zubiao Niu, Bo Zhang, Chenxi Wang, Xiaohong Yao, et al. (+21)
15 [GO] 2021―Jan―26 Antibodies, epicenter of SARS-CoV-2 immunology Simone Pecetta, Mariagrazia Pizza, Claudia Sala, Emanuele Andreano, Piero Pileri, Marco Troisi, et al. (+3)
16 [GO] 2021―Jan―21 COVID-19 vaccines: where we stand and challenges ahead Guido Forni, Alberto Mantovani
17 [GO] 2020―Oct―09 An aberrant STAT pathway is central to COVID-19 Toshifumi Matsuyama, Shawn P. Kubli, Steven K. Yoshinaga, Klaus Pfeffer, Tak W. Mak
18 [GO] 2020―Jun―08 Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) Chiara Agrati, Alessandra Sacchi, Veronica Bordoni, Eleonora Cimini, Stefania Notari, Germana Grassi, et al. (+20)
19 [GO] 2020―Mar―23 COVID-19 infection: the perspectives on immune responses Yufang Shi, Ying Wang, Changshun Shao, Jianan Huang, Jianhe Gan, Xiaoping Huang, et al. (+4)
 [1] 

19 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec